Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Peking University People's Hospital · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
drug-resistance
drug resistance to famitinib and camrelizumab, biomarkers for efficacy and toxicity, osteosarcoma, 5hmc, drug resistance, famitinib, camrelizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.